A0A2R9BLB0 (A0A2R9BLB0_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
Melan-A UniProtKBInterProSTRINGInteractive Modelling
118 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: Q16655, A0A384MR46; Pan troglodytes: A0A6D2Y8E9, A0A2J8M4U8; Gorilla gorilla gorilla: G3RJG3
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1 |
Heteromer P01903; P01911; Q16655; | 100 | ||||
| Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant epitope |
Heteromer P04439; P61769; Q16655; | 70.0 | 4×GOL; | |||
| Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide |
Heteromer P04439; P61769; Q16655; | 100 | 2×GOL; 1×NA; | |||
| Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant |
Heteromer P04439; P61769; Q16655; | 70.0 | ||||
| Structure determination of an enhanced affinity TCR, a24b17, in complex with HLA-A*02:01 presenting… |
Heteromer A0A5B8RNS7; P61769; Q16655; | 100 | 5×GOL; 7×EDO; 5×SO4; 3×TAM; | |||
| Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant |
Heteromer P04439; P61769; Q16655; | 70.0 | ||||
| MA2-MART1-HLAA0201 |
Heteromer A0A140T9X5; P61769; Q16655; | 90.0 | 3×GOL; | |||
| Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant |
Heteromer P04439; P61769; Q16655; | 80.0 | ||||
| Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… |
Heteromer P01848; P01850; P04439; P61769; Q16655; | 90.0 | 2×EPE; 7×SO4; | |||
| RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 |
Heteromer A0A075B6T6; A0A0K0K1A5; P04439; P61769; Q16655; | 90.0 | ||||
| The complex between high affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … |
Heteromer P04439; P61769; Q16655; | 90.0 | ||||
| The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… |
Heteromer P01848; P04439; P61769; Q16655; | 90.0 | ||||
| The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… |
Heteromer A0A075B6T6; A0A1B0GXE1; K7N5M4; P01848; P04439; P61769; Q16655; | 90.0 | ||||
| Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor |
Heteromer P01848; P01850; P61769; Q16655; Q8WLS4; | 90.0 | 2×GOL; 2×SO4; | |||
| Structural basis for ineffective T-cell responses to MHC anchor residue improved heteroclitic pepti… |
Heteromer P04439; P61769; Q16655; | 100 | 4×EDO; | |||
| human 199.54-16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 |
Heteromer A0A075B6T6; A0A0C4ZKA8; A0A5B3; K7N5N2; P04439; P61769; Q16655; | 90.0 | 1×SCN; 2×K; 1×CL; | |||
| MHC Class I A02 Allele presenting EAAGIGILTV, in complex with Mel8 TCR |
Heteromer A0A140T913; P61769; Q16655; | 100 | 2×EDO; | |||
| human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 |
Heteromer A0A075B6N1; P01848; P04439; P61769; Q16655; | 90.0 | 1×NA; | |||
| Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L su… |
Heteromer P04439; P61769; Q16655; | 88.89 | 3×GOL; 3×FMT; 1×NA; | |||
| Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide |
Heteromer P04439; P61769; Q16655; | 100 | 4×GOL; 1×NA; | |||
| Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L su… |
Heteromer P04439; P61769; Q16655; | 88.89 | 4×GOL; 1×NA; | |||
| Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide |
Heteromer P04439; P61769; Q16655; | 100 | 2×GOL; | |||
| The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … |
Heteromer K7N5M3; K7N5M4; P04439; P61769; Q16655; | 100 | ||||
| The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… |
Heteromer P01848; P04439; P61769; Q16655; | 100 | ||||
| The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide |
Heteromer P04439; P61769; Q16655; | 88.89 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6jxr.1.C | monomer | 0.74 | 25.81 | |||